Polyglutamine diseases are a class of inherited neurodegenerative disorders, characterized by expansion of CAG trinucleotide repeats translated into elongated glutamine tracts within the mutant proteins. Overexpression of the non-coding hsrω transcripts has been shown to dominantly enhance polyQ induced cytotoxicity in Drosophila. In the present study we demonstrate that RNA interference mediated downregulation of hsrω-n transcripts is sufficient to suppress pathogenesis in several Drosophila models of human polyQ neurodegenerative diseases. Loss of hsrω-n RNA not only suppresses the eye-specific degeneration mediated by GMR-GAL4 driven expression of the 127Q or MJDtr-Q78 or ataxin1 82Q or httex1p Q93 transgene, but also rescues premature death of flies expressing the expanded polyQ proteins pan-neuronally using the elav-GAL4 driver. We further demonstrate that the morphological and functional rescue of polyQ toxicity observed upon hsrω-n RNAi is associated with substantial reduction of polyQ protein aggregation without affecting transcription of the 127Q transgene. Unlike in the polyQ expressing cells, co-expression of hsrω-n RNAi also abolishes the induction of Hsp70. These results suggest that the hsrω transcripts have a role in early stages of polyQ aggregate formation. Interestingly, hsrω-RNAi has, at best, only a marginal effect on neuropathy following overexpression of normal or mutant tau protein in flies. Functional analogues of the large non-coding hsrω transcripts in human thus appear to be promising candidates as therapeutic targets for the polyQ-mediated neurodegenerative diseases.
Introduction
Expansion of CAG trinucleotide repeats coding for polyglutamine tracts in unrelated proteins causes several disorders, including Huntington's disease (HD), Kennedy's disease (SBMA), dentatorubro-pallidoluysian atrophy (DRPLA) and several types of spinocerebellar ataxias (SCA1, 2, 3, 6, 7, 17) , all of which show dominant, late-onset and progressive neurodegeneration. 1 Each disease is characterized by degeneration of distinct groups of neurons even though the mutant proteins are expressed in wider range of neural and other tissues. Distinct clinical and pathological features of the various polyQ diseases indicate that the protein context around the pathogenic repeat plays a significant role in modulating the disorder. [2] [3] [4] A unifying hallmark of these diseases is the formation of intracellular aggregates or inclusion bodies (IB) due to abnormal folding of the expanded polyQ proteins in the affected neurons in humans as well as in cell culture and animal models. [5] [6] [7] [8] Although the pathological consequences of these IBs are debated (see Discussion), they sequester a variety of cellular proteins like molecular chaperones, some key transcription factors, [9] [10] [11] proteasome subunits 12, 13 and cytoskeletal components. 14, 15 The possible intrinsic toxicity of insoluble aggregates of proteins with expanded polyQ-tract is believed to be aggravated by the sequestration and consequent functional depletion of the other normal cellular proteins, 16, 17 culminating in death of sensitive neuronal cells and thus in neurodegeneration.
An earlier genetic screen utilizing P-insertion alleles identified the non-coding hsrω gene as a dominant modifier of polyQ pathogenesis in fly models. 18 Further detailed studies in our laboratory confirmed aggravation of polyQ-induced eye degeneration by over-or mis-expression of the hsrω gene. 19 The hsrω gene of Drosophila, situated at the 93D4 band position on the right arm of chromosome 3 (http://flybase.org), is expressed in a developmentally regulated manner in nearly all the embryonic, larval and adult cell types. 20 It produces multiple non-coding transcripts. 21 The >10 Kb nucleus limited hsrω-n transcript organizes the nucleoplasmic omega speckles which are believed to regulate nuclear RNA-processing by modulating the availability of hnRNPs and related RNA-processing proteins. [22] [23] [24] A direct interaction between the omega speckles and the expanded polyQ proteins did not appear to be responsible for aggravation of the polyQ pathogenesis following misexpression of hsrω, since neither was the omega speckle organization affected by the pathogenic polyQ proteins nor did the polyQ inclusion bodies colocalize with the hsrω-n transcripts or the hnRNPs. 19 Thus, the molecular mechanism/s by which the non-coding hsrω transcripts modulate polyQ pathogenesis remain to be understood.
With a view to understand the mechanism and to examine if the polyQ pathogenesis could be slowed or reduced by downregulating levels of the hsrω transcripts, we first established transgenic flies designed to conditionally ablate the nucleus limited hsrω-n RNA using the UAS/GAL4 expression system. 25 To elucidate the ability of hsrω-RNAi to prevent polyQ-induced toxicity, we used four different fly models for expanded polyQ pathogenesis, viz. (1) a polyglutamine tract of 127 residues, UAS-127Q, 26 (2) SCA1, UAS-ataxin1 82Q, 18 27 and (4) HD, UAS-httex1p Q93. 10 In this paper, we establish a robust ability of hsrω-RNAi to inhibit polyQ aggregation, to suppress polyQ-induced eye degeneration, and most importantly to rescue premature death in the different polyQ disease models, bolstering the view that all these diseases share a common pathologic mechanism and this mechanism occurs critically in the nucleus. Interestingly, neuropathies caused due to overexpression of wild type or mutant forms of tau are not significantly affected by levels of the hsrω transcripts. The previously reported suppressors of polyQ toxicity have been either proteins or miRNA. 12, [28] [29] [30] [31] [32] [33] [34] In contrast, our present observations identify a large non-coding RNA whose absence dramatically suppresses the polyQ damage. Our results thus open new therapeutic paradigms for these diseases.
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Results
Appropriate genetic crosses were made to co-express one of the two hsrω-RNAi transgenes (hsrω-RNAi 2 and hsrω-RNAi 3 , with the transgene inserted on chromosome 2 and 3, respectively) and/or one of the two EP alleles of hsrω (EP3037 and EP93D, see Materials and Methods) in the background of GMR-GAL4 or elav-GAL4 driven expression of one of the four expanded pathogenic polyQ transgenes or of the unexpanded nonpathogenic UAS-20Q (control for UAS-127Q), UAS-MJDtr-Q27 (control for UAS-MJDtr-Q78(S)), or UAS-httex1p Q20 (control for UAS-httex1p Q93) transgenes, as required. The two hsrω-RNAi transgenic lines, viz., hsrω-RNAi 2 and hsrω-RNAi 3 , generally had similar effects although in a few instances the hsrω-RNAi 2 transgene gave a better rescue than the hsrω-RNAi 3 transgene. The results presented in this paper, unless stated otherwise, are those obtained with the hsrω-RNAi 3 transgene and in the following, hsrω-RNAi refers to the hsrω-RNAi 3 transgene.
GAL4 activation of hsrω-RNAi specifically depletes the nucleus limited hsrω-n transcripts. We established hsrω-RNAi transgenic lines carrying the 280 bp hsrω gene specific repeat sequence flanked by two oppositely oriented UAS regulatory elements to bring about RNAi of the large hsrω-n transcript when activated with the GAL4 driver. We used GMR-GAL4 driver to activate both the hsrω-RNAi and the polyQ transgenes in developing eye discs and adult eyes. To examine whether expression of hsrω-RNAi effectively reduces level of the endogenous hsrω-n RNA, semi-quantitative RT-PCR was performed with RNA isolated from adult fly heads using hsrω-n transcript specific primers (see Materials and Methods). The levels of hsrω-n transcripts in different samples expressing either the pathogenic polyQ protein alone or in conjunction with hsrω-RNAi were compared. As shown (Fig. 1) , in lanes 4, 5, 7 and 9, the level of hsrω-n transcripts was significantly reduced though not completely absent in each case when compared to the respective control genotypes (Fig. 1B, lanes 1, 6 and 8 ). G3PDH levels were determined as an internal control to show that variation in the level of hsrω-n transcripts in the different samples was not due to variations in loading.
Fluorescent in situ hybridization with a hsrω-n specific riboprobe to cellular RNA followed by immunostaining with the P11 antibody, which recognizes the Drosophila Hrb87F protein, also demonstrated that GMR-GAL4 mediated depletion of hsrω-n RNA dramatically reduces the number of omega speckles from 6-8 in polyQ expressing larval eye disc cells to about 2-3 in those co-expressing the polyQ and the hsrω-RNAi transgenes (compare D and G in Fig. 1 ). In parallel, the Hrb87F protein in the nucleus was less in speckles but more in diffuse form (compare E and H in Fig. 1 ). Thus decreased level of the hsrω-n transcripts results in reduced sequestration of hnRNPs like Hrb87F in the omega speckles.
GMR-GAL4 driven expression of hsrω-RNAi transgene suppresses expanded polyQ-induced neurodegeneration in eyes. As reported earlier, 19, 26 expression of UAS-127Q in all eye cells using the GMR-GAL4 driver resulted in collapsed adult eyes with loss of pigmentation and disruption of the regular array of ommatidia (N = 608, Fig. 2A and D) . Co-expression of two copies of the hsrω-RNAi transgene nearly completely suppressed the 127Q eye phenotype in approximately 54% (N = 1105) of flies ( Fig. 2C  and F ). In the remaining 46%, the eyes still showed signs of degeneration but the pigmentation and regularity of the ommatidial array were significantly improved ( Fig. 2B and E) . One copy of hsrω-RNAi also mitigated the 127Q damage (not shown) but the proportion of flies showing near complete recovery was less (32%, N = 193) than that seen with two copies of hsrω-RNAi.
Phalloidin staining of eyes of freshly emerged 127Q expressing adult flies showed complete disruption of retinal structure leading to loss of photoreceptor neurons and appearance of large vacuoles in the tissue (arrow in Fig. 2G ). Co-expression of two copies of hsrω-RNAi resulted in substantial improvement in morphology of the photoreceptor neurons with majority of ommatidia showing the normal seven rhabdomeres (Fig. 2I ) and near complete rescue in external morphology of adult eyes ( Fig. 2C and F) . In the case of flies exhibiting partial rescue also, the internal structure of the retina was significantly better (Fig. 2H ) than in eyes expressing 127Q alone (Fig. 2G) .
In agreement with the earlier report, 19 either of the two overexpressing EP alleles of hsrω (EP3037 and EP93D), when driven level of degeneration primarily induced by 127Q expression (Fig.  2K and M) .
We also examined efficacy of the hsrω-RNAi transgene in the other fly models of human polyQ diseases, viz., those carrying the full length ataxin1, truncated ataxin3 or mutated huntingtin with GMR-GAL4, significantly enhanced 127Q-induced degeneration leading to formation of extensive black lesions on the eye surface ( Fig. 2J and L) . Interestingly, co-expression of a single copy of hsrω-RNAi not only eliminated the enhancing effect of the EP3037 or EP93D alleles but also substantially reversed the ( Fig. 3H and K) almost completely suppressed the MJDtr-Q78 eye phenotype such that none of these flies (N = 835) could be distinguished from wild type in the external appearance of eyes as revealed in nail polish imprints (Fig. 3K) . Pseudopupil images of MJDtr-Q78 and hsrω-RNAi co-expressing eyes, however, revealed incomplete recovery of the rhabdomere arrays (not shown).
The Drosophila Huntington disease model is characterized by age-dependent neurodegeneration and protein translocation rather than aggregation. 35 Thus, all the freshly emerged flies expressing GMR-GAL4 driven 5'-truncated mutant human huntingtin in Drosophila without ( Fig. 3C and F) or with ( Fig. 3I and L) co-expression of hsrω-RNAi transgene showed normal ommatidial morphology. Photoreceptor morphology as seen in pseudopupil exon 1 transgene with expanded polyQ tracts. GMR-GAL4 driven expression of the UAS-ataxin1 82Q transgene, producing the full length human mutated SCA1 protein, resulted in depigmented adult eyes with moderate roughening (N = 437, Fig. 3A ). Nail polish imprints showed that the ommatidial arrays were intact, although a little disorganized (Fig. 3D) . Co-expression of two copies of hsrω-RNAi transgene in this background restored pigmentation of adult eyes and also reduced their roughening (N = 494, Fig. 3G and J).
As reported earlier by Warrick et al. 27 GMR-GAL4 driven expression of MJDtr-Q78(S) induced substantial degeneration in eyes with loss of external pigmentation and eye morphology (N = 762, Fig. 3B and E). Co-expression of two copies of hsrω-RNAi 3 127Q or ataxin1 82Q or MJDtr-Q78(S) or httex1p Q93 transgene in the absence of or in concert with single copy of hsrω-RNAi to all neurons using the elav-GAL4 driver. 38 elav-GAL4 driven expression of a single copy of hsrω-RNAi or of any of the non-pathogenic polyQ transgenes (UAS-20Q or UAS-MJDtr-Q27 or UAS-httex1p Q20) in an otherwise wild type background did not have any adverse effect on survival or longevity of flies (Fig. 5) .
), GMR-GAL4/ UAS-127Q; hsrω-RNAi 3 /+ (bars 2, 3), GMR-GAL4/UAS-127Q; hsrω-RNAi 3 /hsrω-RNAi 3 (bars 4, 5), GMR-GAL4/UAS-MJDtr-Q78(S); +/+ (bar 6), GMR-GAL4/UAS-MJDtr-Q78(S); hsrω-RNAi 3 /+ (bar 7), GMR-GAL4/ UAS-MJDtr-Q78(S); hsrω-RNAi 3 /hsrω-RNAi 3 (bar 8), GMR-GAL4/UAShttex1p Q93; +/+ (bar 9), GMR-GAL4/UAS-httex1p Q93; hsrω-RNAi
Expression of elav-GAL4 driven 127Q protein in the nervous system resulted in complete lethality between late larval and early pupal stages (Fig. 5A ). Co-expression of a single copy of hsrω-RNAi with 127Q increased the proportion of flies surviving to adulthood from 0% to 97.7% (Table 1 , Fig. 5A ). Further, their median and maximum life spans (49 days and 84 days, respectively) were comparable with those expressing the non-pathogenic 20Q protein (Fig. 5A ).
All the progeny expressing elav-GAL4 driven MJDtr-Q78(S) died as fully differentiated pharates, which failed to eclose. Co-expression of a single copy of hsrω-RNAi helped 94.3% of the SCA3 pupae to successfully emerge from the pupal case (Table 1 , Fig. 5B ). However, the surviving female flies displayed abdominal swellings and became lethargic over time. Median lifespan of flies co-expressing hsrω-RNAi and MJDtr-Q78(S) was only 13 days ( Fig. 5B) .
Pan-neuronal expression of ataxin1 82Q resulted in death of 48% of the progeny as early embryos and the rest before adult emergence, with majority dying as undifferentiated pupae (Table  1) . Co-expression of one copy of hsrω-RNAi significantly lowered the proportion of progeny dying at each stage of development, such that a greater fraction of the progeny now died as differentiated pharates (Table 1) .
Expression of httex1p Q93 under the elav-GAL4 driver yielded adults with a substantially shortened median life span of 12 days (Table 1 , Fig. 5C ). However, co-expression of hsrω-RNAi with the httex1p Q93 transgene prolonged the median and maximum lifespan of adult HD flies to become comparable with flies expressing the non-pathogenic httex1p Q20 protein (see Table 1 , Fig. 5C ).
Downregulation of hsrω-n transcripts inhibits polyQ protein aggregation. The aggregation of polypeptides with expanded polyglutamine tracts, a hallmark pathological feature of polyQ diseases, is associated with induction of Hsp70 in the affected cells. 39, 40 Therefore, we examined if the dominant suppression of polyglutamine-induced degeneration by hsrω-n RNAi also affected the polyQ inclusion bodies (IB) and induction of Hsp70. Eye discs from late third instar larvae expressing either UAS-127Q alone or in combination with hsrω-RNAi were co-immunoassayed for polyQ aggregation and the stress-inducible Hsp70. In addition to a diffuse cytoplasmic staining for polyQ in eye discs expressing 127Q alone (N = 17), numerous intranuclear and cytoplasmic IBs were also present (Fig. 6A) ; all these cells also showed significant presence of Hsp70 (Fig. 6D) . However, polyQ IBs and the Hsp70 protein were completely absent in about 46% of eye imaginal discs (N = 28) co-expressing hsrω-RNAi and UAS-127Q under control of the GMR-GAL4 driver ( Fig. 6C and F, respectively). The status of polyglutamine aggregates in the remaining 54% discs from revealed that the rhabdomeres in flies expressing mutant huntingtin alone showed damage with age (Fig. 4B) . Co-expression of the hsrω-RNAi transgene with the 5'-truncated human huntingtin substantially inhibited the age-dependent degeneration in rhabdomeres since the pseudopupil images of eye in such 10 days old flies (Fig. 4C ) revealed very few irregularities in the arrangement of rhabdomeres.
Co-expression of EP3037 in the mutant SCA3 and huntingtin expressing eye discs aggravated the damage as in the 127Q model (not shown). It may further be noted that even single copy of any of the two hsrω-RNAi transgenes substantially rescued neurodegeneration caused by expression of any of the pathogenic polyQ proteins (data not shown).
Functional rescue of polyQ-mediated toxicity. To check whether the rescue of eye degeneration by hsrω-n RNAi correlates with functional restoration of photoreceptor rhabdomeres, phototaxis assay was performed. In this behavioral assay the functionality of vision in two day (for 127Q and MJDtr-Q78(S)) and 10 day old (in case of httex1p Q93) flies was tested by analyzing the choice of selection between light and dark (Fig. 4D) . As reported previously, the 127Q 28 and MJDtr-Q78 36 expressing flies failed to detect light and randomly moved to light and dark chambers when given a choice (Fig. 4D , bar 1 and 6, respectively). Co-expression of one (Fig. 4D , bars 2, 3 and 7) or two (Fig. 4D , bars 4, 5 and 8) copies of the hsrω-RNAi transgene restored the vision, since increasing numbers of these flies chose the illuminated chamber. 127Q expressing adult flies with near complete recovery of external and internal eye morphology following co-expression of one or two copies of the hsrω-RNAi transgene exhibited near complete restoration of vision as evident by their movement towards the lighted chamber (Fig. 4D , bars 3 and 5) while amongst those showing partial rescue, a smaller proportion of flies moved to the lighted chamber, although this was also significantly higher than in only 127Q expressing flies. In case of the adult-onset HD model, retinal toxicity was evident in the form of impaired phototactic behaviour of 10 days old flies (Fig. 4D, bar 9 ). However, majority of the httex1p Q93 flies co-expressing either one (Fig. 4D , bar 10) or two (Fig. 4D, bar 11 ) copies of the hsrω-RNAi transgene retained normal vision at day 10. Statistical analysis using t-test for comparison of means of % positively phototactic flies in the various sets in Figure 4D revealed that the proportion of positively phototactic flies is significantly greater (p < 0.05) in those co-expressing the hsrω-RNAi transgene compared to those expressing only the corresponding expanded polyQ transgene alone, except in the case of flies co-expressing httex1p Q93 and one copy of hsrω-RNAi (bars 9 and 10 in Fig. 4D ). Thus, reduced levels of hsrω-n transcripts not only improved external and internal eye structure of the expanded polyQ expressing flies but also significantly rescued their functionality.
Depletion of hsrω transcripts diminishes polyglutamine protein toxicity in the nervous system in Drosophila. Since panneuronal expression of expanded polyQ proteins in Drosophila is known to cause neuronal apoptosis and organismal death, 37 we examined if depletion of hsrω transcripts modulates polyQ toxicity in the nervous system as well. We targeted expression of either these discs was less (Fig. 6 , compare D and E) indicating a reduction in the stress burden following hsrω-RNAi in the polyQ expressing cells.
Larval eye discs expressing MJDtr-Q78(S) alone or together with hsrω-RNAi under GMR-GAL4 driver were also immunoassayed for the polyQ protein. As already reported, 27 MJDtr-Q78 was cytoplasmic in cells closer to the MF but was recruited to the nucleus to form prominent IBs in differentiating photoreceptor cells in the proximal part, away from the MF, of the developing eye disc (Fig. 6G and H) . In eye discs, co-expressing hsrω-RNAi and MJDtr-Q78(S), the number and size of nuclear inclusion bodies were significantly reduced ( Fig. 6I and J) . In order to quantify this difference, we counted the number of rows behind the morphogenetic furrow in which the IBs were not seen in the two sets of eye discs. In MJDtr-Q78(S) expressing discs (N = 8), IBs were seen beginning from the 5 th to 7 th row behind the furrow. However, co-expression of hsrω-RNAi delayed IB formation since in these discs the IBs were seen only in more posterior regions, i.e., 9-11 rows behind the furrow (N = 10).
The above findings were further corroborated by western blotting. It was seen that following GMR-GAL4 driven expression of 127Q (Fig. 6K, lane 3) or MJDtr-Q78(S) (Fig. 6K, lane  4) , bulk of the expanded polyQ proteins from adult fly heads remained either trapped in the stacking gel or moved in the separating gel as a series of slow migrating bands, reflecting them to be high-molecular weight aggregates or oligomers, respectively, while the monomers moved further ahead (Fig. 6, lanes 3 and  4) . The high molecular weight polyQ aggregates in the stacking gel were largely absent in adult heads co-expressing 127Q and hsrω-RNAi and showing nearly full recovery of eye phenotype (Fig. 6K, lane 1) but those exhibiting partial rescue of the 127Q phenotype showed only a partial reduction of aggregates (Fig.  6K, lane 2) . GMR-GAL4 driven co-expression of MJDtr-Q78(S) and hsrω-RNAi (Fig. 6K, lane 5 ) also resulted in substantial reduction in polyQ protein accumulation in the stacking gel. It is notable that the polyQ oligomers in fly heads expressing GMR-GAL4 driven 127Q and two copies of the hsrω-RNAi transgene and showing full recovery of eye phenotype were also less abundant (Fig. 6K, lane 1) . For reasons that are not clear, the sizes of various oligomers and possible monomers of the 127Q and MJDtr-Q78(S) proteins in the gel appear similar in spite of some differences in the putative molecular sizes of their monomeric forms. It is possible that presence of the long polyQ stretches affects their folding which in turn affects their gel migration even in the presence of SDS in the polyacrylamide gel. 41 However, it is significant that in parallel with the rescue of eye degeneration, the polyQ aggregates also appear to be reduced or abolished by co-expression of the hsrω-RNAi transgene.
Absence of polyQ aggregates following expression of hsrω-RNAi transgene is not a consequence of inhibition of polyQ transcription. With a view to examine if absence of the polyQ protein from 50% of the larval eye discs expressing 127Q and hsrω-RNAi was due to transcriptional inhibition of the polyQ transgene, we determined the levels of 127Q transcripts in the presence or absence of co-expressed hsrω-RNAi by semi-quantitative RT-PCR. Figure 7A shows that 127Q transcript levels were hsrω-RNAi and UAS-127Q expressing larvae, however, did not appear to be much different from those expressing 127Q alone (Fig. 6, compare A and B) although the Hsp70 protein level in proteins. To address whether the suppressive effect of hsrω-n RNAi was selective to polyQ-induced neurodegenerative diseases or was a common feature applicable to neurodegeneration in general, we examined the effect of depletion or increased expression of the hsrω transcripts on neuropathies caused by overexpression of wild type or mutant forms of the human tau protein. Directed expression of wild type ( Fig. 8A and E) or the Fronto-temporal dementias with Parkinsonism linked to chromosome 17 (FTDP-17) associated mutant V337M (Fig. 8I and M) or R406W ( Fig. 8Q and U) tau protein in the retina using the GMR-GAL4 driver produced rough and reduced eye phenotypes ( Fig. 8A and E, I , M, Q and U), more prominently in eyes expressing the R406W mutant tau protein (Fig. 8Q and U) . Co-expression of hsrω-RNAi did not have any significant effect on the rough/reduced eye phenotypes caused due to expression of either the wild type ( Fig. 8B and F) or R406W ( Fig. 8R and V) mutant tau, although, a mild suppression was observed in case of the mutant V337M tau-induced eye degeneration (Fig. 8J and  N) . GMR-GAL4 driven overexpression of hsrω transcripts using the EP93D (Fig. 8C and G, K, O, S and W) or the EP3037 (Fig.  8D and H, L, P, T and X) allele failed to enhance either the wild type or mutant tau-induced pathology. Thus, the neuroprotective effects of downregulation of the hsrω transcripts appear to be restricted to glutamine repeat disorders. not significantly altered by downregulation of hsrω transcripts, demonstrating that the rescue of polyglutamine-mediated degeneration observed here is not a consequence of reduced transcription of the 127Q transgene. It is interesting to note that the levels of 127Q transcripts were essentially similar in adult heads expressing the 127Q transgene without (Fig. 7, lane 2 , GMR-GAL4/UAS-127Q; +/+) or with co-expressed hsrω-RNAi transgene (Fig. 7, lanes 3, 4 GMR-GAL4/UAS-127Q; hsrω-RNAi/hsrω-RNAi) and irrespective of partial (Fig. 7, lane 3) or near complete (Fig. 7, lane 4) rescue of the eye degeneration because of reduced levels of hsrω transcripts.
Furthermore, we also examined if hsrω-n RNA ablation has any other non-specific effect on the GAL4/UAS system due to the presence of multiple UAS-transgenes in the genome. For this purpose, we examined GMR-GAL4 driven expression of a UAS-LacZ or a UAS-GFP reporter transgene in larval eye discs expressing either 127Q alone or both the 127Q and the hsrω-RNAi transgenes. It was seen that X-gal staining for the β-galactosidase reporter enzyme or the GFP levels in the two sets of discs were indistinguishable (Fig. 7 , compare B and C and D and E, respectively). This confirms that in our experimental system, the GMR promoter driven GAL4 protein does not become limiting in the presence of additional UAS targets. Figure 6 . Accumulation of polyglutamine aggregates is varyingly suppressed by depletion of hsrω-n transcripts in 127Q or MJDtr-Q78 expressing eye discs. both of which markedly reduce the levels of hsrω-n transcripts (Mallik M, Lakhotia SC, in preparation) in cells where their expression is directed. A possible reason for the lowered levels of polyQ aggregates in the hsrω-RNAi expressing cells could be that as the numbers of UAS-carrying transgenes increase, the GMR-driven GAL4 protein becomes limiting and thus results in reduced activity of the target transgenes. However, our results show that the presence of multiple UAS carrying transgenes (hsrω-RNAi and mutant polyQ) did not functionally deplete cellular levels of the GAL4 protein since neither the level of polyQ transcripts nor the expression of UAS-LacZ or UAS-GFP reporter genes was affected by increasing the number of target UAS sequences. Further, co-expression of UAS-hsrω-RNAi transgene and any of the two EP alleles of hsrω in the polyQ background not only suppressed the enhancing effects of the EP allele but also substantially reversed the basic 127Q-induced cytotoxicity. Taken together, present observations clearly show that suppression of polyQ toxicity by hsrω-RNAi is a specific effect of the reduction in the levels of this non-coding RNA. In addition to rescuing the structural integrity of ommatidia, RNAi-mediated depletion of hsrω transcripts nearly completely restored their functionality as revealed by the phototaxis assay.
Efficacy of the suppressive effect of depletion of hsrω-n is limited to neurodegeneration caused by the expanded polyQ
(A-J) Confocal projections of third instar larval eye imaginal discs from GMR-GAL4/UAS-127Q; +/+ (A and D), GMR-GAL4/UAS-127Q; hsrω-RNAi 3 /hsrω-RNAi 3 (B, C, E and F), GMR-GAL4/UAS-MJDtr-Q78(S); +/+ (G and H) and GMR-GAL4/UASMJDtr-Q78(S); hsrω-RNAi
Our results further show that the suppressive effects of reduced levels of hsrω transcripts on polyQ pathogenesis are not restricted to eye cells but extend pan-neuronally. As expected, elav-GAL4 driven widespread expression of the various polyQ proteins in the nervous system resulted in near complete lethality early in development or at the pupal stage. Restoration of viability of adults to near normal levels following hsrω-RNAi indicates global modulation of polyQ toxicity in the fly models by these non-coding transcripts. The somewhat varying degree of suppression observed in the different Drosophila polyQ disease models following hsrω RNAi is in agreement with the earlier known 42, 43 importance of the protein context flanking the expanded polyQ repeat in modulating the disease phenotypes.
IBs are hallmarks of polyQ pathogenesis but whether they are causal to or a consequence of disease pathogenesis or represent
Discussion
Following an earlier report from our laboratory 19 that altered/ enhanced expression of the non-coding hsrω gene aggravates polyQ-mediated neurodegeneration in eyes, our present results demonstrate that RNAi-mediated depletion of the hsrω-n transcripts effectively suppresses the aggregation and neurotoxicity of expanded polyQ proteins in several fly models. This suppression was seen with two independent UAS-hsrω-RNAi transgenic lines, reduced than in those expressing polyQ alone (Fig. 6) . Since the induction of Hsp70 in 127Q and hsrω-RNAi co-expressing cells correlated with the extent of IBs present following downregulation of hsrω-n RNA, we believe that hsrω-RNAi indeed reduces the cellular stress by reducing or completely eradicating polyQ aggregates.
Amelioration of polyQ-induced toxicity by overexpression of transcriptional regulators like CBP or of the hnRNPs seems to operate through suppression of polyQ aggregate formation or by supplementation of the cellular pools of these essential proteins which are known to be trapped in the pathogenic aggregates. 28, 55 One of the essential cellular functions of the hsrω-n transcripts is to regulate the availability and trafficking of hnRNPs and several a cellular protective mechanism is debated. 27, [44] [45] [46] Our study, however, suggests a strong correlation between polyQ aggregation and neurodegeneration. An almost complete inhibition of IB formation seen in ~50% of larval eye discs co-expressing 127Q and hsrω-RNAi was paralleled by a complete suppression of polyQ toxicity in ~50% of adult eyes and absence of SDS-insoluble polyQ protein in western blots. Likewise, flies that showed partial recovery in adult eyes also showed some amount of SDS-insoluble polyQ aggregates in western blots and parallely IBs were still present in such eye discs (Figs. 2 and 6 ). This correlation is further supported by the observation that in case of the SCA3 model, where ablation of hsrω transcripts only delayed and partially reduced the formation of IBs, the adult eyes still showed internal damage and likewise, the lifespan of flies, expressing the mutant SCA3 transgene under elav-Gal4 driver was also only partially restored.
Our results show that suppression of the polyQ induced neurodegeneration following hsrω-RNAi is not due to inhibition of transcription of the polyQ transgene since RT-PCR analysis revealed that the levels of these transcripts did not differ between flies showing the 127Q phenotype or those with partial or near complete recovery because of hsrω-n RNAi. This observation, together with the reduced incidence of IBs and enhanced solubility of polyQ proteins in hsrω-RNAi expressing eye discs, as seen after immunostaining and western-blotting, respectively, suggests that hsrω-RNAi rescues neurodegeneration primarily by reducing the formation of toxic polyQ aggregates rather than by inhibiting polyQ transcription. Since the hsrω-n transcript levels have also been reported to affect cellular translation, 47 it remains possible that the translation of polyQ transcripts is affected by hsrω-RNAi and, therefore, the incidence of polyQ aggregates gets reduced or eliminated. However, our other observations (Mallik M and Lakhotia SC, under preparation) show that the suppression of polyQ damage by hsrω-RNAi requires efficient proteasomal activity and that overexpression of hsrω compromises proteasomal function. Thus we believe that hsrω-RNAi expression prevents formation of the polyQ aggregates which permits the cellular protein degradation system to remove the monomers more effectively and thus diminish the polyQ toxicity.
Several studies in recent years have identified a number of factors which reduce or eliminate polyQ toxicity through their actions prior to the formation of insoluble aggregates of the expanded polyQ proteins while others act further downstream through resolubilization of the aggregates or through prevention of cell death of the affected cells (reviewed in ref. 48) . Conditions that prevent formation of insoluble aggregates or IBs include overexpression of heat shock proteins 39, 49 or CREB Binding Protein (CBP 28 ) or downregulation of the Drosophila Apaf-1 related killer, Dark. 50 Overexpression of Hsp70 is known to rescue polyQ toxicity 39, 51, 52 although with respect to polyQ aggregates, overexpression of Hsp70 is reported to either abolish them 53 or to have no effect. 54 Our present results show that the reduction/disappearance of IBs following hsrω-n RNAi is not due to enhanced levels of Hsp70 since in the present case, the level of Hsp70 in cells co-expressing hsrω-RNAi and expanded polyQ was actually (reviewed in ref. 56 ). Since the hsrω-n transcript extends more than 10 kb, 21 it remains possible that during its RNAi mediated breakdown, some other miRNAs maybe generated which may affect other gene transcripts. We performed a BLAST analysis of the NR_002068 sequence, corresponding to 14.084 kb hsrω-n transcript with the Drosophila melanogaster genome assembly available on http://flybase. org. This revealed that a stretch of 22 bp in the intronic region (961b to 982b of the NR_002068 sequence) of hsrω shares 100% identity with a region in the 3 rd intron of the RD transcript of the frizzled 2 gene. In addition, a 21 bp region in the 280 bp repeat unit of the hsrω gene showed complete identity with sequences in some natural transposons like copia and 1360. It remains to be seen if these regions can actually generate functional miRNAs which can regulate activity of the frizzled 2 gene or the natural transposons and if any of this has a role in polyQ pathogenesis. If this indeed turns out to be true, it will be an additional pathway for hsrω gene's action.
Our other unpublished results show that hsrω-RNAi can effectively suppress induced apoptosis and can also repress activation of JNK pathway, (ref. 57 and Mallik M, Lakhotia SC, in preparation) both of which are implicated in polyQ pathogenesis. 58 It appears therefore, that in addition to preventing the primary toxicity of the mutant polyQ proteins, hsrω-RNAi further suppresses neurodegeneration by reducing or eliminating the secondary consequences of the insoluble aggregates through reduction in transcriptional dsyregulation and inhibition of cell death.
Contrary to the conventional dogma that non-coding DNA/ RNA are essentially "junk" or "evolutionary hangovers", it is becoming increasingly clear that they have prime roles in generating the eukaryotic complexity. 59 While many of the small non-coding RNAs act through a complex network of regulation of transcription and translation of other mRNAs, the large non-coding RNAs perform regulatory functions either by providing a platform for binding with a variety of proteins or through direct association with complementary DNA sequence or through as yet unknown mechanisms. 23, [59] [60] [61] [62] The hsrω-n transcripts in Drosophila appear other RNA-binding proteins. [21] [22] [23] [24] It is likely that reduced levels of the hsrω transcripts following RNAi releases the hnRNPs that are normally sequestered in omega speckles and thus counterbalances their functional depletion by the polyQ aggregates. Our other studies (Mallik M and Lakhotia SC, in preparation) show that reduction in hsrω transcripts results in enhanced levels of CBP, a condition which, as noted above, reduces polyQ aggregation. We believe that hsrω-RNAi thus reduces aggregation of the pathogenic polyQ proteins into IBs and also facilitates increased availability of hnRNPs and CBP in the functional cellular pools (Mallik M, Lakhotia SC, in preparation).
In an earlier study, Bilen et al. 34 reported that upregulation of the ban (bantam) miRNA mitigates the damage in SCA3 fly model while downregulation of Dicer activity, resulting in global reduction of miRNA production, enhanced the SCA3 toxicity transposon present in the roundabout (robo) gene on chromosome 2. This line, like the parental one from which it was derived, was associated with male sterility in the homozygous state. As in case of the parental hsrω 05241 stock, 69 recessive male sterility in the derived EP93D line was also due to a second site mutation which was recombined out. Likewise, recessive embryonic lethality in the original EP3037 stock was also recombined out. The EP3037 and EP93D alleles carry the EP transposon at the -144 bp and -130 bp position, respectively, in the hsrω gene promoter. Both are homozygous viable and fertile, although the fertility is partially affected.
Appropriate crosses were performed following standard protocols to obtain progenies of desired genotypes. GMR-GAL4 driver was used in combination with the desired responder gene/s for their targeted expression in developing eye disc cells. 70 In order to drive expression of the different UAS-carrying responders pan-neuronally, appropriate crosses were made to introduce the X-chromosome linked elav-GAL4 driver.
Longevity assay. For assaying longevity, flies carrying the elav-GAL4 driver and the desired UAS-responder gene/s were collected within 8-12 hr of eclosion and maintained at 23 ± 1°C. In the case of SCA1, only female progeny flies were examined since the UAS-ataxin1 82Q transgene insertion is also on the X-chromosome. The number of dead flies was counted every day and the survivors transferred to fresh food-vials at 2-3 days interval. At least three replicates were examined for each genotype.
Examination of eye structure. For recording images of external morphology of adult eyes, flies of the desired genotype were etherized and their eyes photographed using a Sony Digital Camera (DSC-75) attached to a Zeiss Stemi SV6 stereobinocular microscope.
The surface architecture of adult eyes was examined by preparing nail polish imprints of 1-2 day old adult flies as described by Arya and Lakhotia. 71 Briefly, adult flies of the desired genotype/(s) were anaesthetized, decapitated and the head dipped in a drop of transparent nail polish kept on a clean glass slide. After a few minutes, the dried nail polish layer was peeled off from the eyes and examined under a Nikon E800 microscope using a 20X DIC objective.
The arrangement of photoreceptor rhabdomeres in adult eyes (wild type or those expressing various transgenes) was visualized by the pseudopupil method using a 60X oil bright field objective on a Nikon E800 microscope as described earlier. 19 In some cases, the retinal structure in adult eyes was examined by staining with 1:200 dilution of phalloidin-TRITC (Sigma-Aldrich, India) followed by confocal microscopy.
Phototaxis assay. Phototaxis was performed as previously described. 72 Briefly, a group of ~15-20 flies were introduced into a Y-maze (modified from Quinn et al. 72 ), where one arm was illuminated from an outside light source while the other arm and the stem of the Y were wrapped with a black paper and thus were completely dark inside. Flies were introduced into the stem of the Y-maze, agitated lightly and then allowed to phototactically run into the maze for 60 seconds. Flies in both the chambers were anesthetised and counted separately. At least three independent experiments (with three replicates in each case) were performed to regulate cellular activities through binding with a large variety of other regulatory proteins. 22, 24 The present study provides the first example of a large noncoding RNA that can substantially suppress the polyQ damage. It is significant that the levels of hsrω transcripts affect the polyQ toxicity specifically since modulation in their levels does not affect tau-induced neurodegeneration. It will be interesting to see if some of the non-coding human RNAs that are expressed in mammalian brain 63, 64 or the human sat III non-coding transcripts, which seem to be functionally analogous to the hsrω transcripts, 24 have comparable activity. This would provide a new paradigm for therapeutic strategies for management of polyQ diseases.
Materials and Methods
Drosophila genetics. Fly stocks were maintained at 23 ± 1°C. For cytological preparations, staged larvae were grown in Pteri dishes on food supplemented with additional yeast for healthy growth. Following fly stocks were used in the present study:
( 3 (generated in our laboratory)
The transgenic UAS-hsrω-RNAi 2 and UAS-hsrω-RNAi 3 fly lines used in this study were established by cloning the 280 bp hsrω-n specific repeat motif 21 in the SympUAST-w vector, 68 which has two oppositely oriented UAS sequences to drive simultaneous expression of both sense and anti-sense strands in the presence of GAL4. Among the overexpressing EP alleles of hsrω, EP3037 was obtained from the Bloomington stock center and was initially associated with recessive embryonic lethality. The EP93D allele was generated in our laboratory by swapping the P-LacZ-ry + transposon at the -130 bp position in the hsrω 05241 allele with an EP 45 seconds at 60°C (in case of hsrω-n and G3PDH) or 30 seconds at 62°C (in case of 127Q); 1 minute at 72°C and final extension for 5 minutes at 72°C. The PCR products were electrophoresed on a 2% agarose gel with appropriate molecular weight markers.
Immunoblotting. To compare polyQ protein levels in different genetic backgrounds, extracts from adult heads of the following genotypes: w; UAS-127Q/GMR-GAL4; +/+, w; UAS-127Q/ GMR-GAL4; UAS-hsrω-RNAi 3 /UAS-hsrω-RNAi 3 , w; UAS-MJDtr-Q78(S)/GMR-GAL4; +/+ and w; UAS-MJDtr-Q78(S)/GMR-GAL4; UAS-hsrω-RNAi 3 /UAS-hsrω-RNAi 3 , respectively, were lysed in sample buffer 74 and homogenized. The lysates were separated electrophoretically on 12% SDS-Polyacrylamide gel (with 5% stacking gel) and transferred to immobilon-P membrane (Millipore, USA). The primary antibodies used were: 1:200 dilution of mouse anti-β-tubulin E7 antibody (Developmental Studies Hybridoma Bank, USA) and 1:300 dilution of anti-HA. Immunoblots were developed with horse-radish peroxidase-conjugated secondary antibodies (1:1,500 dilution of goat anti-mouse or goat anti-rabbit, Bangalore Genei, India) using an enhanced chemiluminescence detection system (Pierce, USA). Blots were re-probed, as required, after stripping the earlier bound antibodies by incubation in 100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris, pH = 6.8 at 50°C for 30 min.
for each genotype with ~60 flies examined per genotype. In each experiment, the number of flies moving to the lighted arm was converted into % value and the mean % value (±SD) was calculated for three experiments. The replicates gave good reproducible scores for each genotype as revealed by low standard deviations of the mean (Fig. 4D) . t-test was used for assessing the statistical significance of the differences in mean % values for genotypes expressing the given polyQ transgene in absence or presence of one or two copies of the hsrω-RNAi transgene.
X-gal staining of third instar larval eye discs. X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) staining of LacZ expressing third instar larval eye imaginal discs of the desired genotype/(s) was performed as described earlier. 20 Whole organ immunostaining and confocal microscopy. Eye discs from wandering third instar larvae of the desired genotypes were dissected and immunostained with the desired antibodies as described previously. 23 Following primary antibodies were used:
(1) 1:30 dilution of a rabbit polyclonal antibody to haemagglutinin (HA) (sc-805, Santa Cruz, USA) for HA-tagged 127Q and MJDtr-Q78(S) polyglutamine proteins.
(2) 1:200 dilution of the 7Fb rat monoclonal antibody 73 for stress-inducible form of Hsp70.
Appropriate secondary antibodies conjugated either with Cy3 (1:200, Sigma-Aldrich, India) or Alexa Fluor 488 (1:200, Molecular Probes, USA) were used to detect the given primary antibody. Chromatin was counterstained with DAPI. Samples were examined either on a Biorad Radiance 2000 multiphoton laser scanning confocal microscope or a Zeiss LSM 510 Meta laser scanning confocal microscope at appropriate settings using planapo 40X or 60X or 63X oil immersion objective.
Reverse transcription-PCR (RT-PCR).
For RT-PCR analysis, total RNA was prepared from heads of adult flies of the desired genotype using TRIzol reagent following the manufacturer's recommended protocol (Sigma-Aldrich, India). RNA pellets were resuspended in nuclease-free water and quantitated spectrophotometrically. The samples were incubated with RNase-free DNaseI (MBI fermentas, USA) for 30 minutes at 37°C. First strand cDNA was synthesized from 5 μg of total RNA using 200 units of M-MuLV reverse transcriptase (New England Biolabs, USA) and 80 pmol of oligo d(T) 18 primer (New England Biolabs, USA). One-tenth volume of the reaction mixture was subjected to PCR using the following primers: hsrω-n: Forward primer 5'-GGA AAC AAT GAA ACC ATA CGC-3'
Reverse primer 5'-TTG CGC TCA CAG GAG ATC AA-3' 127Q: Forward primer 5'-CAG CGT CCT GAT AAG TGA ATT CG-3'
Reverse primer 5'-TAC GTA CGA CTA GTC TGT TGC TG-3' G3PDH: Forward primer 5'-CCA CTG CCG AGG AGG TCA ACT A-3'
Reverse primer 5'-GCT CAG GGT GAT TGC GTA TGC A-3'
The thermal cycling parameters included an initial denaturation at 94°C (4 minutes) followed by 35 cycles of 45 seconds at 94°C,
